Mirror Therapy and Cross-Education of Muscle Strength

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

29 participants

Study Classification

INTERVENTIONAL

Study Start Date

2020-02-01

Study Completion Date

2021-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study was conducted to determine whether mirror therapy has an additive effect on cross-education of the strength of neuromuscular electrical stimulation (NMES) in patients with hemiplegia. As an outcome measure, the ankle dorsiflexion strength of hemiplegic patients was measured.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Cold Therapy and Cross-Education of Muscle Strength

NCT04886843

Cerebrovascular Stroke Muscle Weakness

COMPLETED NA

Evaluation of the Effects of Neuromuscular Electrical Stimulation and Mirror Therapy in Hemiplegia Rehabilitation

NCT04913506

Hemiplegia Upper Extremity Dysfunction

UNKNOWN NA

Upper Limb Cross-education in Subacute Stroke

NCT04113369

Hemiplegia Stroke

COMPLETED NA

Neuromuscular Electrical Stimulation (NMES) in Stroke-diagnosed Individuals

NCT03811106

Hemiplegia

UNKNOWN NA

Effects Of Sensory Training and Electrical Stimulation on Sole of The Foot Sensations in Patients With Acute Hemiplegia

NCT04252092

Hemiplegia Stroke, Acute Sensory Disorders

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

A total of 29 patients, 7 women, and 22 men were included according to the inclusion and exclusion criteria. The patients were randomly assigned to the control group (n = 14) and the Mirror group (n = 15). Five sessions of neuromuscular electrical stimulation, unaffected side ankle dorsiflexors were applied to the patients in both groups. In addition to the NMES, mirror therapy was applied to the experimental group simultaneously with NMES. Before and after treatment, both ankle dorsiflexor strength was measured with a force sensor. For force measurements, a force transducer (FC2211-0000-0100-L Compression Load Cell, TE Connectivity company, France) was used. Force transducer signals were received with a data acquisition device (POWERLAB® data acquisition system ADInstruments, Oxford, UK) and evaluated offline on the computer. The measurement values were expressed in kilogram.force (kg.f) and this value was normalized according to body weight.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cerebrovascular Stroke Muscle Weakness

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Randomized controlled trial

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Mirror Therapy

Participants were asked to sit with their knee joints in full extension and both ankle joints in a neutral position. Five sessions of neuromuscular electrical stimulation (NMES) were applied to the non-affected side ankle dorsiflexors. In addition to this application, mirror therapy was applied simultaneously with NMES.

Group Type ACTIVE_COMPARATOR

Mirror frame

Intervention Type DEVICE

Combined Mirror and NMES therapy

Control

Participants were asked to sit with their knee joints in full extension and both ankle joints in a neutral position. Five sessions of neuromuscular electrical stimulation (NMES) were applied to the non-affected side ankle dorsiflexors.

Group Type PLACEBO_COMPARATOR

Control

Intervention Type DEVICE

Only NMES therapy

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Mirror frame

Combined Mirror and NMES therapy

Intervention Type DEVICE

Control

Only NMES therapy

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Cases with stroke duration ≥ 1 month
* Ability to walk at least 10m (functional ambulation scale ≥3)
* Age range 18-75 years
* Hemorrhagic or ischemic stroke
* Brunnstrom stage ≥4 for lower limb
* Unilateral stroke
* Cooperating with the examination and tests

Exclusion Criteria

* Mini Mental State Assessment score \<21
* Severe spasticity (MAS = 4) in ankle dorsiflexors
* Have a contracture on ankle joint
* The presence of skin lesions in the application area
* Painful pathologies in the lower extremities
* Having visual field defects
* Active inflammatory, rheumatological or infectious disease
* Parent rhythm / conduction block problem in the heart
* Uncontrollable hypertension (Maxima\> 140, Minima\> 90)
* Presence of lower extremity fracture
* Peripheral nerve lesions such as polyneuropathy, radiculopathy
* Finding or suspected active deep vein thrombosis
* History of deep vein thrombosis and pulmonary embolism

Minimum Eligible Age

18 Years

Maximum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No